Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating the efficacy and safety of WXSH0102 for vaginitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WXSH0102

Snippet

Sponsor: Cisen Pharmaceutical CO., LTD. | Conditions: Vaginitis | Phase 2 | Status: RECRUITING